10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended September 30, 2003.

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from _____________ to _____________.

Commission file number 000-31173

ChipPAC, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware	77-0463048
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

47400 Kato Road, Fremont, California 94538

(Address of Principal Executive Offices, Zip Code)

Registrant’s Telephone Number, Including Area Code (510) 979-8000

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b.2 of the Act). Yes x No ¨

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class	Outstanding as of November 10, 2003
Class A common stock, $.01 par value	97,030,964
Class B common stock, $.01 par value	None

TABLE OF CONTENTS

		Page
PART I    FINANCIAL INFORMATION
Item 1.	Financial Statements
	Unaudited Condensed Consolidated Balance Sheets	3
	Unaudited Condensed Consolidated Statements of Operations	4
	Unaudited Condensed Consolidated Statements of Cash Flows	5
	Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	22
PART II    OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 2.	Changes in Securities and Use of Proceeds	23
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Submission of Matters to a Vote of Security Holders	23
Item 5.	Other Information	23
Item 6.	Exhibits and Reports on Form 8-K	23
Signatures		27
Certifications

2

ChipPAC, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

(Unaudited)

	September 30, 2003			December 31, 2002
ASSETS
Current assets:
Cash and cash equivalents	$	38,090		$	34,173
Short-term investments		43,022			10,000
Accounts receivable, less allowances for doubtful accounts of $455 and $391		44,891			38,793
Inventories		20,941			15,299
Prepaid expenses and other current assets		9,100			5,285
Total current assets		156,044			103,550
Property, plant and equipment, net		360,110			336,397
Intangible assets, net		15,949			17,300
Other assets		18,913			12,957
Total assets	$	551,016		$	470,204
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	48,910		$	39,755
Accrued expenses and other current liabilities		25,714			29,400
Total current liabilities		74,624			69,155
Long-term debt		165,000			217,887
Convertible subordinated notes		200,000			50,000
Other long-term liabilities		21,528			17,618
Total liabilities		461,152			354,660
Stockholders’ equity :
Common stock, Class A—par value $0.01 per share; 250,000 shares authorized, 96,606 and 94,093 shares issued and outstanding at September 30, 2003 and December 31, 2002, respectively		966			941
Additional paid-in capital		283,017			276,916
Receivables from stockholders		(241	)		(480	)
Accumulated other comprehensive income		9,169			9,169
Accumulated deficit		(203,047	)		(171,002	)
Total stockholders’ equity		89,864			115,544
Total liabilities and stockholders’ equity	$	551,016		$	470,204

The accompanying notes are an integral part of these financial statements.

3

ChipPAC, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2003			2002			2003			2002
Revenue	$	105,420		$	94,659		$	300,832		$	270,958
Cost of revenue		92,385			78,699			261,169			227,679
Gross profit		13,035			15,960			39,663			43,279
Operating expenses:
Selling, general and administrative		10,313			9,362			28,244			28,982
Research and development		2,729			2,550			8,689			7,258
Restructuring charge and write-down of impaired assets		13,619			—			13,619			—
Total operating expenses		26,661			11,912			50,552			36,240
Operating income (loss)		(13,626	)		4,048			(10,889	)		7,039
Non-operating (income) expenses:
Interest expense		7,914			7,691			22,804			24,479
Interest income		(287	)		(242	)		(596	)		(455	)
Foreign currency (gains) losses		303			(547	)		519			860
Gain on sale of building		(3,929	)		—			(3,929	)		—
Loss from early debt extinguishment		—			—			1,182			3,005
Other income, net		(208	)		(175	)		(324	)		(478	)
Total non-operating expenses		3,793			6,727			19,656			27,411
Loss before income taxes		(17,419	)		(2,679	)		(30,545	)		(20,372	)
Provision for income taxes		500			500			1,500			1,500
Net loss	$	(17,919	)	$	(3,179	)	$	(32,045	)	$	(21,872	)
Net loss per share:
Net loss per share available to common stockholders
Basic	$	(0.19	)	$	(0.03	)	$	(0.34	)	$	(0.26	)
Diluted	$	(0.19	)	$	(0.03	)	$	(0.34	)	$	(0.26	)
Weighted average shares used in per share calculation:
Basic		95,710			93,421			95,065			85,166
Diluted		95,710			93,421			95,065			85,166

The accompanying notes are an integral part of these financial statements.

4

ChipPAC, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	For the Nine Months Ended September 30,
	2003			2002
Cash flows from operating activities:
Net loss	$	(32,045	)	$	(21,872	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		50,879			42,947
Amortization of debt issuance costs		1,584			1,832
Foreign currency losses		519			860
Write-down of impaired assets		11,662			—
Loss from early debt extinguishment		1,182			3,005
Gain on sale of building		(3,929	)		—
Gain on sale of equipment		(371	)		(65	)
Changes in assets and liabilities:
Accounts receivable		(6,098	)		(5,849	)
Inventories		(5,642	)		(3,552	)
Prepaid expenses and other current assets		(3,898	)		(1,587	)
Other assets		(3,320	)		(4,857	)
Accounts payable		9,155			4,021
Accrued expenses and other current liabilities		(3,686	)		(27	)
Other long-term liabilities		1,824			4,796
Net cash provided by operating activities		17,816			19,652
Cash flows from investing activities:
Purchases of short-term investments		(154,618	)		—
Proceeds from sale of short-term investments		121,596			—
Acquisition of property and equipment		(75,660	)		(57,999	)
Acquisition of intangible assets		(2,279	)		(2,544	)
Proceeds from sale of building		5,399			—
Proceeds from sale of equipment		479			86
Acquisition of test assets		(3,500	)		—
Malaysian acquisition, net of cash and cash equivalents acquired		(3,475	)		(5,873	)
Net cash used in investing activities		(112,058	)		(66,330	)
Cash flows from financing activities:
Proceeds from revolving loan and other lines of credit		27,704			105,596
Repayment of revolving loan and other lines of credit		(27,704	)		(105,596	)
Debt issuance costs		(180	)		(703	)
Net proceeds from long-term debt		144,861			16,700
Repayment of long-term debt		(52,887	)		(82,440	)
Repayment of notes from stockholders		239			505
Proceeds from common stock issuance		6,126			167,105
Repurchase of common stock		—			(24	)
Net cash provided by financing activities		98,159			101,143
Net increase in cash		3,917			54,465
Cash and cash equivalents at beginning of period		34,173			41,872
Cash and cash equivalents at end of period	$	38,090		$	96,337

The accompanying notes are an integral part of these financial statements.

5

ChipPAC, Inc.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the Quarter Ended September 30, 2003

(Unaudited)

Note 1:    Interim Statements

In the opinion of management of ChipPAC, Inc. (“ChipPAC” or the “Company”), the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting solely of normal recurring adjustments) necessary to present fairly the financial information included therein. This financial data should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2002 included in ChipPAC’s 2002 Annual Report on Form 10-K. The accompanying unaudited condensed consolidated financial statements include the accounts of ChipPAC, Inc and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Certain prior period balances have been reclassified to conform to the current period presentation.

The results of operations for interim periods are not necessarily indicative of the results of operations that may be expected for any other period or the fiscal year that ends on December 31, 2003. The interim period ended on September 28, 2003, the Sunday nearest September 30th.

Recent Accounting Pronouncements

In May 2002, the FASB issued SFAS No. 145, “Rescission of SFAS Nos. 4, 44, and 64, Amendment of SFAS No. 13, and Technical Corrections.” Among other things, SFAS No. 145 rescinds various pronouncements regarding early extinguishment of debt and allows extraordinary accounting treatment for early extinguishment only when the provisions of Accounting Principles Board Opinion No. 30, “Reporting the Results of Operations—Reporting the Effects of Disposal of a Segment of a Business and Extraordinary, Unusual and Infrequently Occurring Events and Transactions” are met. SFAS No. 145 provisions regarding early extinguishment of debt are generally effective for fiscal years beginning after May 15, 2002. In the second quarter of 2003, the Company has reclassified a loss on extinguishment of debt that was previously classified as an extraordinary item in prior periods but did not meet the criteria in APB Opinion No. 30 for classification as an extraordinary item and has included it within income from continuing operations.

In June 2002, the FASB issued SFAS No. 146, “Accounting for Exit or Disposal Activities.” SFAS No. 146 addresses significant issues regarding the recognition, measurement, and reporting of costs that are associated with exit and disposal activities, including restructuring activities that are currently accounted for under EITF No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring).” The scope of SFAS No. 146 also includes costs related to terminating a contract that is not a capital lease and termination benefits that employees who are involuntarily terminated receive under the terms of a one-time benefit arrangement that is not an ongoing benefit arrangement or an individual deferred-compensation contract. SFAS No. 146 is effective for exit or disposal activities that are initiated after December 31, 2002 and early application is encouraged. The Company adopted SFAS No. 146 during the first quarter of fiscal year 2003. The effect on adoption of SFAS No. 146 changes on a prospective basis the timing of when restructuring charges are recorded from a commitment date approach to when the liability is incurred.

In November 2002, the Financial Accounting Standards Board issued FASB Interpretation No. 45, or FIN 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others.” FIN 45 requires that a liability be recorded in the guarantor’s balance sheet upon issuance of a guarantee. In addition, FIN 45 requires disclosures about the guarantees that an entity has issued, including a reconciliation of changes in the entity’s product warranty liabilities. The initial recognition and initial measurement provisions of FIN 45 are applicable on a prospective basis to guarantees issued or modified after December 31, 2002, irrespective of the guarantor’s fiscal year-end. The Company adopted FIN 45 in the first quarter of 2003 and has met the disclosure requirements of FIN 45. The adoption of FIN 45 has no material impact on the Company’s financial statements.

In November 2002, the Emerging Issues Task Force, or EITF, reached a consensus on Issue No. 00-21, “Revenue Arrangements with Multiple Deliverables.” EITF Issue No. 00-21 provides guidance on how to account for arrangements that involve the delivery or performance of multiple products, services and/or rights to use assets. The provisions of EITF Issue No. 00-21 will apply to revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company has adopted EITF Issue No. 00-21. The adoption of EITF Issue No. 00-21 has no material impact on the Company’s financial statements.

In December 2002, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 148, “Accounting for Stock-Based Compensation, Transition and Disclosure.” SFAS No. 148 provides alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based employee compensation. SFAS No. 148 also requires that disclosures of the pro forma effect of using the fair value method of accounting for stock-based

6

employee compensation be displayed more prominently and in a tabular format. Additionally, SFAS No. 148 requires disclosure of the pro forma effect in interim financial statements. The transition and annual disclosure requirements of SFAS No. 148 are effective for fiscal years ended after December 15, 2002. The interim disclosure requirements are effective for interim periods beginning after December 15, 2002. The Company adopted SFAS No. 148 in the first quarter of 2003. The adoption of SFAS No. 148 has no material impact on its financial statements.

In January 2003, the Financial Accounting Standards Board issued FASB Interpretation No. 46, or FIN 46, “Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51.” FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective immediately for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after December 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

In May 2003, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 150, “Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity,” SFAS No. 150 establishes standards for how an issuer classifies and measures certain financial instruments with characteristics of both liabilities and equity. SFAS No. 150 requires that an issuer classify a financial instrument that is within its scope as a liability (or an asset in some circumstances). SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003, and otherwise is effective at the beginning of the first interim period beginning after June 15, 2003. The Company believes that the adoption of this standard will have no material impact on its financial statements.

Stock-Based Compensation

The Company has adopted the disclosure only provisions of SFAS No. 123. Accordingly, no compensation expense has been recognized for the Company’s stock option and purchase plan activity as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. If compensation expense had been determined based on the grant date fair value for awards, in accordance with the provisions of SFAS No. 123, the Company’s net loss and loss per share would have been adjusted to the pro forma amounts indicated below:

	Three Months Ended September 30,						Nine Months Ended September 30,
	(In thousands, except for per share amounts)						(In thousands, except for per share amounts)
	2003			2002			2003			2002
Net loss as reported	$	(17,919	)	$	(3,179	)	$	(32,045	)	$	(21,872	)
Add: Total stock-based employee compensation included in net loss, net of related tax effects		—			—			—			—
Deduct: Total stock-based employee compensation expenses determined under fair value method for awards, net of related tax effects		1,706			1,109			3,490			3,605
Pro forma net loss	$	(19,625	)	$	(4,288	)	$	(35,535	)	$	(25,477	)
Net loss per share as reported:
Basic	$	(0.19	)	$	(0.03	)	$	(0.34	)	$	(0.26	)
Diluted	$	(0.19	)	$	(0.03	)	$	(0.34	)	$	(0.26	)
Pro forma net loss per share:
Basic	$	(0.21	)	$	(0.05	)	$	(0.37	)	$	(0.30	)
Diluted	$	(0.21	)	$	(0.05	)	$	(0.37	)	$	(0.30	)
Weighted average shares used in per share calculation:
Basic		95,710			93,421			95,065			85,166
Diluted		95,710			93,421			95,065			85,166

The following assumptions were used to determine the pro forma impact of accounting for stock options issued during the three and nine months ended September 30, 2003 and September 30, 2002: (1) risk-free interest rate of 2.9% and 2.5%, respectively, (2) dividend yield of 0.0%, (3) expected life of four years, and (4) volatility of 58.4% and 53.3%, respectively.

7

Note 2:    Selected Balance Sheet Accounts

The components of inventories were as follows (in thousands):

	September 30, 2003		December 31, 2002
Raw materials	$	16,973	$	11,198
Work in process		3,696		3,293
Finished goods		272		808
	$	20,941	$	15,299

Property, plant and equipment were comprised of the following (in thousands):

	September 30, 2003			December 31, 2002
Land use rights	$	11,171		$	12,368
Buildings and improvements		69,218			66,404
Equipment		573,624			529,710
		654,013			608,482
Less accumulated depreciation and amortization		(293,903	)		(272,085	)
	$	360,110		$	336,397

Other assets were comprised of the following (in thousands):

	September 30, 2003		December 31, 2002
Deposits	$	1,006	$	836
Long-term, non-executive, employee loans		1,017		802
Debt issuance costs, net of amortization of $4,700 and $5,944		12,765		10,132
Other		4,125		1,187
	$	18,913	$	12,957

Intangible assets balances are summarized as follows (in thousands):

	September 30, 2003						December 31, 2002
	Gross Assets		Accumulated Amortization		Net Assets		Gross Assets		Accumulated Amortization		Net Assets
Intellectual property	$	16,491	$	6,715	$	9,776	$	15,734	$	4,980	$	10,754
Software and software development		16,187		10,385		5,802		14,231		8,460		5,771
Licenses		4,497		4,126		371		4,422		3,647		775
	$	37,175	$	21,226	$	15,949	$	34,387	$	17,087	$	17,300

Amortization expense for intangible assets is summarized as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2003		2002		2003		2002
Intellectual property	$	594	$	535	$	1,735	$	1,572
Software and software development		679		659		1,925		1,947
Licenses		183		134		479		242
	$	1,456	$	1,328	$	4,139	$	3,761

8

Intangible assets are being amortized over estimated useful lives of three to seven years. Estimated future amortization expense is as follows (in thousands):

October 1, 2003 to December 31, 2003	$	1,489
2004		4,892
2005		4,341
2006		3,304
2007		1,497
Thereafter		426
Total	$	15,949

Accrued expenses and other liabilities were comprised of the following (in thousands):

	September 30, 2003		December 31, 2002
Payroll and related items	$	14,814	$	14,778
Interest payable		5,893		9,210
Other expenses		5,007		5,412
	$	25,714	$	29,400

In the three month period ended September 30, 2003, ChipPAC’s management approved restructuring plans to realign its organization and reduce operating costs. These actions were designed to better align the Company’s workforce and to reduce operating expenses. These plans were a combination of reductions in work force and employee furloughs. Restructuring charges of $1.9 million were expensed during the three month period ended September 30, 2003. As of September 30, 2003, the Company has reduced its work force by 252 employees. Components of the accrued restructuring costs and amount charged for restructuring as of September 30, 2003 are as follow (in thousands):

	Accrual		Expenditure		Balance September 30, 2003
Employee separations	$	1,957	$	1,417	$	540

Note 3:    Line of Credit and Other Bank Borrowings

Line of Credit

The Company has a borrowing capacity of $50.0 million for working capital and general corporate purposes under the revolving credit line portion of its senior credit facility. The revolving credit line under the senior credit facility matures on July 31, 2005. During the three month period ended September 30, 2003, the Company did not utilize any borrowings against this revolving line of credit and as of September 30, 2003, there was no outstanding balance on the revolving line of credit and the entire $50.0 million was available to the Company.

The Company has also established two separate lines of credit with Korean Exchange Bank and Cho Hung Bank, with credit limits of $4.0 million and $8.0 million, respectively. During the three month period ended September 30, 2003, no borrowings were made against either of these lines of credit. Both agreements are subject to an annual review by Korean Exchange Bank and Cho Hung Bank for the continued use of the credit line facility. The Company also has a line of credit available with Southern Bank Bhd. for $0.5 million. During the three month period ended September 30, 2003, the Company borrowed $0.3 million against this line of credit loan for general corporate purposes at the interest rate of 6.9% per annum. As of September 30, 2003, there was no outstanding balance on this credit line.

Other Borrowings

        On May 28, 2003, the Company issued $125.0 million of 2.5% convertible subordinated notes due 2008 in a private placement and on June 5, 2003, the initial purchaser exercised the option to purchase an additional $25.0 million of 2.5% senior subordinated notes under the same terms. The $150.0 million of 2.5% convertible subordinated notes are convertible into shares of the Company’s Class A common stock at a conversion price of $8.062 per share, subject to adjustment, at any time prior to June 1, 2008, and bear an interest rate of 2.5% per annum. The Company used $63.9 million from the proceeds of these notes to pay down term loans of $36.2 million, a foreign loan of $16.7 million and revolving loans of $11.0 million. The remaining $61.1 million is being used for general corporate purposes. On October 3, 2003, the Company filed a registration statement with the Securities Exchange Commission on Form S-3, which is not yet effective, for these notes along with the shares of common stock into which the notes are convertible.

As of September 30, 2003, the Company’s total debt consisted of $365.0 million of borrowings, which was comprised of $165.0 million of 12.75% senior subordinated notes, $50.0 million of 8.0% convertible subordinated notes and $150.0 million of 2.5% convertible subordinated notes.

Note 4:    Common Stock Offerings

On January 30, 2002, the Company sold 10,000,000 shares of Class A common stock in an underwritten public offering for $6.00 per share. On February 14, 2002, the Company sold an additional 1,425,600 shares of Class A common stock in conjunction with the underwriter’s exercise of their over-allotment option for $6.00 per share. In connection with these sales, the Company received net proceeds of approximately $63.8 million, after deducting underwriting discounts, commissions and

9

estimated offering expenses. Net proceeds of $62.4 million from this offering were used to pay down term loans and revolving loans. The remaining $1.4 million was used for general corporate purposes.

On May 30, 2002, the Company sold 12,000,000 shares of Class A common stock in an underwritten public offering for $8.75 per share. In connection with these sales, the Company received net proceeds of approximately $99.2 million, after deducting underwriting discounts, commissions and estimated offering expenses. Net proceeds of $50.0 million from this offering were used to pay down term loans and revolving loans. The remaining $49.2 million was used for general corporate purposes.

Sources and Use of Funds From Issuance of Common Stock

	January 2002 Offering			May 2002 Offering			Totals
Source of funds:
Gross proceeds from issuance of common stock	$	68,554		$	105,000		$	173,554
Less: related issuance costs		(4,768	)		(5,830	)		(10,598	)
Net proceeds from issuance of common stock	$	63,786		$	99,170		$	162,956
Use of funds:
Repayment of senior credit facilities	$	62,438		$	50,000		$	112,438
General corporate purposes		1,348			49,170			50,518
	$	63,786		$	99,170		$	162,956

Note 5:    Acquisition of Malaysian Business

On June 30, 2000, the Company consummated the acquisition of Intersil’s packaging and test operations located in Kuala Lumpur, Malaysia, along with related intellectual property for approximately $71.5 million in cash and preferred stock. Additionally, in 2000, $2.4 million of other purchase price adjustments were recorded based on the difference between the final closing balance sheet and the estimated closing balance sheet of the Malaysian business. The terms of the acquisition of the Malaysian business required the Company to pay additional contingent incentive payments to Intersil of approximately $17.9 million based on the achievement of milestones. Cumulatively, as of September 30, 2003, $17.9 million of contingent incentive payments have been made and the Company recorded these contingent payments as additional purchase price. Deferred tax of $5.6 million has been recorded on all of these adjustments, which resulted in a further increase of the effective purchase price and non-current assets.

There was no goodwill arising from the acquisition of the Malaysian business. The fair value of total assets and liabilities exceed the purchase price by $56.2 million as of July 1, 2000. This amount, reduced by the additional contingent incentive payments, other purchase price adjustments and related deferred taxes, as of September 30, 2003, has been allocated in full to non-current assets as summarized below:

Non-current assets	Estimated Fair Value		Initial Excess of Fair Value of Acquired Net Assets Over Cost			Total Additional Purchase Price		Adjusted Fair Value
	(in millions)
Land and buildings	$	27.9	$	(11.1	)	$	4.9	$	21.7
Plant and equipment		93.9		(36.9	)		17.9		74.9
Intellectual property		20.9		(8.2	)		3.1		15.8
	$	142.7	$	(56.2	)	$	25.9	$	112.4

Note 6:    Earnings Per Share

SFAS No. 128 requires a reconciliation of the numerators and denominators of the basic and diluted per share computations. Basic earnings per share (“EPS”) is computed by dividing net income (loss) available to stockholders (numerator) by the weighted average number of shares of common stock outstanding (denominator) during the period. Diluted EPS is computed using the weighted average number of shares of common stock and all potentially dilutive shares of common stock outstanding during the period. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options and the if-converted method is used for determining the number of shares assumed issued from the conversion of the convertible subordinated notes.

10

As of September 30, 2003, there were options outstanding to purchase 8.2 million shares of Class A common stock with a weighted average exercise price of $3.74, which could potentially dilute basic EPS in the future, but were not included in diluted EPS as their effect would have been antidilutive due to the net loss. The Company also has outstanding $50.0 million convertible subordinated notes which are convertible into approximately 5.0 million shares of Class A common stock at $9.96 per share and $150.0 million convertible subordinated notes which are convertible into approximately 18.6 million shares of Class A common stock at $8.062 per share. These were not included in diluted EPS as their effect would also have been antidilutive due to the net loss. The following is a reconciliation of the numerators and denominators of the basic and diluted EPS computations for the periods presented below.

	Three Months Ended September 30, 2003							Three Months Ended September 30, 2002
	Net Loss			Shares	Per-Share Amount			Net Loss			Shares	Per-Share Amount
	(In thousands, except per share amounts)
Basic EPS:
Net loss per share	$	(17,919	)	95,710	$	(0.19	)	$	(3,179	)	93,421	$	(0.03	)
Diluted EPS:
Net loss per share	$	(17,919	)	95,710	$	(0.19	)	$	(3,179	)	93,421	$	(0.03	)
	Nine Months Ended September 30, 2003							Nine Months Ended September 30, 2002
	Net Loss			Shares	Per-Share Amount			Net Loss			Shares	Per-Share Amount
Basic EPS:
Net loss per share	$	(32,045	)	95,065	$	(0.34	)	$	(21,872	)	85,166	$	(0.26	)
Diluted EPS:
Net loss per share	$	(32,045	)	95,065	$	(0.34	)	$	(21,872	)	85,166	$	(0.26	)

Note 7:    Contingent Liabilities

During the quarter ended June 30, 2002, an assessment of approximately 16.0 billion Korean Won (approximately $13.9 million U.S. Dollars at September 30, 2003) was made by the Korean National Tax Administration, or NTA, relating to withholding tax not collected on the loan between the Company’s subsidiaries in Korea and Hungary. The prevailing tax treaty does not require withholding on the transactions in question. There were no further assessments made during the quarter ended September 30, 2003. The Company has appealed the assessment through the NTA’s Mutual Agreement Procedure and believes that the assessment will be overturned. As of September 30, 2003, no accrual has been made. On July 18, 2002, the Icheon tax office of the NTA approved a suspension of the proposed assessment until resolution of the disputed assessment. The NTA required a corporate guarantee of 120% of the assessment in exchange for the suspension. The Company complied with the guarantee request on August 1, 2002. No further assessments have been made.

Note 8:    Acquisition of Cirrus Logic Test Assets

On June 30, 2003, the Company acquired the semiconductor test operation assets of Cirrus Logic, Inc. Pursuant to the Asset Purchase Agreement by and between the Company and Cirrus Logic, the Company has paid Cirrus Logic, Inc., $3.5 million in cash. The terms of the acquisition of the Cirrus Logic semiconductor test operation assets also required the Company to pay until June 30, 2007 additional contingent incentive payments to Cirrus Logic, Inc. based on the achievement of milestones with respect to the transfer of the seller’s test business.

Note 9:    Sale of Building

The Company sold an unutilized building and land, located in its Malaysian facility to Texas Instruments Malaysia for total consideration of $5.5 million. The Company realized a gain of $3.9 million before taxes as a result of the sale.

11

Note 10:    Supplemental Financial Statements of Guarantor/Non-Guarantor Entities

In connection with the recapitalization, in August 1999, ChipPAC International Company Limited, (“CP Int’l”), issued senior subordinated debt securities which are fully and unconditionally guaranteed, jointly and severally, on a senior subordinated basis, by the parent company, ChipPAC, Inc. (“CPI”) and by ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Korea Company Limited (“CPK”), ChipPAC Malaysia Sdn. Bhd. (“CPM”), ChipPAC Luxembourg S.a.R.L., and ChipPAC Liquidity Management Hungary Limited Liability Company (the “Guarantor Subsidiaries”). All Guarantor Subsidiaries are wholly owned direct or indirect subsidiaries of CPI. ChipPAC Shanghai Limited (“CPS”) did not provide guarantees (the “Non-Guarantor Subsidiary”). The following is consolidated financial information for CP Int’l, CPI, CPM, and CPK, CPS, ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Luxembourg S.a.R.L., and ChipPAC Liquidity Management Hungary Limited Liability Company, segregated between the Guarantor and Non-Guarantor Subsidiaries.

12

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEETS

September 30, 2003

(In thousands)

(Unaudited)

	Parent Guarantor CPI			Issuer CP Int’l			Other Guarantors			Non- Guarantor China			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	13,597		$	323		$	22,128		$	2,042		$	—		$	38,090
Short-term investments		37,522			—			5,500			—			—			43,022
Intercompany accounts receivable		173,421			20,036			21,675			16,154			(231,286	)		—
Accounts receivable, net		—			—			44,859			32			—			44,891
Inventories		—			—			17,097			3,844			—			20,941
Prepaid expenses and other current assets		1,428			—			6,727			945			—			9,100
Total current assets		225,968			20,359			117,986			23,017			(231,286	)		156,044
Property, plant and equipment, net		5,098			11,645			245,005			98,362			—			360,110
Intercompany loans receivable		—			202,380			—			—			(202,380	)		—
Investment in subsidiaries		59,043			—			87,233			—			(146,276	)		—
Intangible assets, net		808			—			14,715			426			—			15,949
Other assets		7,655			5,303			5,949			6			—			18,913
Total assets	$	298,572		$	239,687		$	470,888		$	121,811		$	(579,942	)	$	551,016
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Intercompany accounts payable	$	156		$	4,043		$	204,112		$	22,975		$	(231,286	)	$	—
Accounts payable		1,965			32			38,729			8,184			—			48,910
Accrued expenses and other current liabilities		6,587			3,638			10,318			5,171			—			25,714
Total current liabilities		8,708			7,713			253,159			36,330			(231,286	)		74,624
Long-term debt		—			165,000			—			—			—			165,000
Convertible subordinated notes		200,000			—			—			—			—			200,000
Intercompany loans payable		—			—			202,380			—			(202,380	)		—
Other long-term liabilities		—			—			21,528			—			—			21,528
Total liabilities		208,708			172,713			477,067			36,330			(433,666	)		461,152
Stockholders’ equity:
Common stock		966			—			—			—			—			966
Additional paid in capital		283,017			81,689			174,691			149,093			(405,473	)		283,017
Receivables from stockholders		(241	)		—			—			—			—			(241	)
Accumulated other comprehensive income		9,169			—			8,705			464			(9,169	)		9,169
Accumulated deficit		(203,047	)		(14,715	)		(189,575	)		(64,076	)		268,366			(203,047	)
Total stockholders’ equity		89,864			66,974			(6,179	)		85,481			(146,276	)		89,864
Total liabilities and stockholders’ equity	$	298,572		$	239,687		$	470,888		$	121,811		$	(579,942	)	$	551,016

13

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS

Nine Months Ended September 30, 2003

(In thousands)

(Unaudited)

	Parent Guarantor CPI			Issuer CP Int’l			Other Guarantors			Non- Guarantor China			Eliminations			Consolidated
Intercompany revenue	$	19,635		$	1,368		$	—		$	53,409		$	(74,412	)	$	—
Customer revenue		—			—			300,754			78			—			300,832
		19,635			1,368			300,754			53,487			(74,412	)		300,832
Cost of revenue		425			836			284,529			49,791			(74,412	)		261,169
Gross profit		19,210			532			16,225			3,696			—			39,663
Operating expenses:
Selling, general and administrative		15,762			218			9,645			2,619			—			28,244
Research and development		2,274			—			6,186			229			—			8,689
Restructuring and write-down of impaired assets		540			—			9,049			4,030			—			13,619
Total operating expenses		18,576			218			24,880			6,878			—			50,552
Operating income (loss)		634			314			(8,655	)		(3,182	)		—			(10,889	)
Non-operating (income) expenses
Inter-company interest expense		—			—			12,163			1,515			(13,678	)		—
Interest expense		4,819			17,680			305			—			—			22,804
Interest income		(445	)		—			(147	)		(4	)		—			(596	)
Inter-company interest income		—			(13,678	)		—			—			13,678			—
(Income) loss from investment in subsidiaries		28,220			—			4,593			—			(32,813	)		—
Foreign currency loss		(1	)		—			490			30			—			519
Gain on sale of building		—			—			(3,929	)		—			—			(3,929	)
Loss from early debt extinguishment		—			1,099			83			—			—			1,182
Other (income) expenses, net		81			—			(275	)		(130	)		—			(324	)
Total non-operating (income) expense		32,674			5,101			13,283			1,411			(32,813	)		19,656
Income / (loss) before income taxes		(32,040	)		(4,787	)		(21,938	)		(4,593	)		32,813			(30,545	)
Provision for income taxes		5			276			1,219			—			—			1,500
Net income / (loss)	$	(32,045	)	$	(5,063	)	$	(23,157	)	$	(4,593	)	$	32,813		$	(32,045	)

14

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Nine Months Ended September 30, 2003

(In thousands)

(Unaudited)

	Parent Guarantor CPI			Issuer CP Int’l			Other Guarantors			Non- Guarantor China			Eliminations			Consolidated
Cash flows from operating activities:
Net income (loss)	$	(32,045	)	$	(5,063	)	$	(23,157	)	$	(4,593	)	$	32,813		$	(32,045	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		761			836			37,893			11,389			—			50,879
Amortization of debt issuance cost		588			996			—			—			—			1,584
Foreign currency loss		(1	)		—			490			30			—			519
Write-off of impaired assets		—			—			7,632			4,030			—			11,662
Loss from early debt extinguishment		—			1,099			83			—			—			1,182
Gain on sale of building		—			—			(3,929	)		—			—			(3,929	)
Gain on sale of equipment		(5	)		—			(288	)		(78	)		—			(371	)
Equity income (loss) from investment in subsidiaries		28,220			—			4,593			—			(32,813	)		—
Changes in assets and liabilities:
Intercompany accounts receivable		(57,247	)		48,974			1,490			709			6,074			—
Accounts receivable		17			—			(6,098	)		(17	)		—			(6,098	)
Inventories		—			—			(5,002	)		(640	)		—			(5,642	)
Prepaid expenses and other current assets		(459	)		—			(3,959	)		520			—			(3,898	)
Other assets		(78	)		—			(3,246	)		4			—			(3,320	)
Intercompany accounts payable		(803	)		(56,178	)		64,134			(1,079	)		(6,074	)		—
Accounts payable		591			(1,921	)		12,001			(1,516	)		—			9,155
Accrued expenses and other current liabilities		1,310			(5,620	)		1,710			(1,086	)		—			(3,686	)
Other long-term liabilities		2			—			1,852			(30	)		—			1,824
Net cash provided by (used in) operating activities		(59,149	)		(16,877	)		86,199			7,643			—			17,816
Cash flows from investing activities:
Purchases of short-term investments		(149,118	)		—			(5,500	)		—			—			(154,618	)
Proceeds from sale of short-term investments		121,596			—			—			—			—			121,596
Acquisition of property and equipment		38			(6,899	)		(57,736	)		(11,063	)		—			(75,660	)
Acquisition of intangible assets		(474	)		—			(1,805	)		—			—			(2,279	)
Proceeds from sale of building		—			—			5,399			—			—			5,399
Proceeds from sale of equipment		5			—			372			102			—			479
Acquisition of test assets		—			—			(3,500	)		—			—			(3,500	)
Malaysian acquisition, net of cash and cash equivalent acquired		—			—			(3,475	)		—			—			(3,475	)
Investment in subsidiaries		(54,000	)		—			(34,000	)		—			88,000			—
Net cash used in investing activities		(81,953	)		(6,899	)		(100,245	)		(10,961	)		88,000			(112,058	)
Cash flows from financing activities:
Proceeds from revolving loan and other lines of credit		—			26,500			1,204			—			—			27,704
Repayment of revolving loan and other lines of credit		—			(26,500	)		(1,204	)		—			—			(27,704	)
Debt issuance costs		(180	)		—			—			—			—			(180	)
Net proceeds from long-term debt		144,861			—			—			—			—			144,861
Repayment of long-term debts		—			(36,187	)		(16,700	)		—			—			(52,887	)
Intercompany loan payments		—			50,120			(16,120	)		(34,000	)		—			—
Intercompany capital contributions		—			—			54,000			34,000			(88,000	)		—
Repayment of notes from stockholders		239			—			—			—			—			239
Proceeds from common stock issuance		6,126			—			—			—			—			6,126
Net cash provided by financing activities		151,046			13,933			21,180			—			(88,000	)		98,159
Net increase (decrease) in cash		9,944			(9,843	)		7,134			(3,318	)		—			3,917
Cash and cash equivalents at beginning of period		3,653			10,166			14,994			5,360			—			34,173
Cash and cash equivalents at end of period	$	13,597		$	323		$	22,128		$	2,042		$	—		$	38,090

15

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEETS

December 31, 2002

(In thousands)

(Unaudited)

	Parent Guarantor CPI			Issuer CP Int’l			Other Guarantors			Non- Guarantor China			Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	3,653		$	10,166		$	14,994		$	5,360		$	—		$	34,173
Short-term investments		10,000			—			—			—			—			10,000
Intercompany accounts receivable		116,175			69,010			23,165			16,863			(225,213	)		—
Accounts receivable, net		17			—			38,760			16			—			38,793
Inventories		—			—			12,095			3,204			—			15,299
Prepaid expenses and other current assets		968			—			2,852			1,465			—			5,285
Total current assets		130,813			79,176			91,866			26,908			(225,213	)		103,550
Property, plant and equipment, net		5,528			5,582			222,698			102,589			—			336,397
Intercompany loans receivable		—			252,500			—			—			(252,500	)		—
Investment in subsidiaries		33,263			—			57,827			—			(91,090	)		—
Intangible assets, net		703			—			16,018			579			—			17,300
Other assets		2,847			7,398			2,702			10			—			12,957
Total assets	$	173,154		$	344,656		$	391,111		$	130,086		$	(568,803	)	$	470,204
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Current liabilities:
Intercompany accounts payable	$	960		$	60,221		$	139,978		$	24,054		$	(225,213	)	$	—
Accounts payable		1,373			1,953			26,729			9,700			—			39,755
Accrued expenses and other current liabilities		5,277			9,258			8,607			6,258			—			29,400
Total current liabilities		7,610			71,432			175,314			40,012			(225,213	)		69,155
Long-term debt, less current portion		—			201,187			16,700			—			—			217,887
Convertible subordinated notes		50,000			—			—			—			—			50,000
Intercompany loans payable		—			—			218,500			34,000			(252,500	)		—
Other long-term liabilities		—			—			17,618			—			—			17,618
Total liabilities		57,610			272,619			428,132			74,012			(477,713	)		354,660
Stockholders’ equity (deficit):
Common stock		941			—			—			—			—			941
Additional paid in capital		276,916			81,689			120,692			115,093			(317,474	)		276,916
Receivables from stockholders		(480	)		—			—			—			—			(480	)
Accumulated other comprehensive income		9,169			—			8,705			464			(9,169	)		9,169
Accumulated deficit		(171,002	)		(9,652	)		(166,418	)		(59,483	)		235,553			(171,002	)
Total stockholders’ equity (deficit)		115,544			72,037			(37,021	)		56,074			(91,090	)		115,544
Total liabilities and stockholders’ equity (deficit)	$	173,154		$	344,656		$	391,111		$	130,086		$	(568,803	)	$	470,204

16

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS

Nine Months Ended September 30, 2002

(In thousands)

(Unaudited)

	Parent Guarantor CPI			Issuer CP Int’l			Other Guarantors			Non- Guarantor China			Eliminations			Consolidated
Intercompany revenue	$	21,067		$	200		$	—		$	51,080		$	(72,347	)	$	—
Customer revenue		—			—			270,703			255			—			270,958
		21,067			200			270,703			51,335			(72,347	)		270,958
Cost of revenue		—			120			253,259			46,647			(72,347	)		227,679
Gross profit		21,067			80			17,444			4,688			—			43,279
Operating expenses:
Selling, general and administrative		17,613			233			8,261			2,875			—			28,982
Research and development		1,957			—			5,301			—			—			7,258
Total operating expenses		19,570			233			13,562			2,875			—			36,240
Operating income (loss)		1,497			(153	)		3,882			1,813			—			7,039
Non-operating (income) expenses
Inter-company interest expense		—			—			21,254			2,510			(23,764	)		—
Interest expense		3,300			20,724			455			—			—			24,479
Interest income		(291	)		(22	)		(123	)		(19	)		—			(455	)
Inter-company interest income		—			(23,677	)		(87	)		—			23,764			—
Loss from investment in
subsidiaries		20,362			—			809			—			(21,171	)		—
Foreign currency loss		—			—			815			45			—			860
Loss from early debt extinguishment		—			3,005			—			—			—			3,005
Other expenses, net		(5	)		—			(284	)		(189	)		—			(478	)
Total non-operating expenses		23,366			30			22,839			2,347			(21,171	)		27,411
Loss before income taxes		(21,869	)		(183	)		(18,957	)		(534	)		21,171			(20,372	)
Provision for income taxes		3			122			1,100			275			—			1,500
Net loss	$	(21,872	)	$	(305	)	$	(20,057	)	$	(809	)	$	21,171		$	(21,872	)

17

ChipPAC, Inc.

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS

Nine Months Ended September 30, 2002

(In thousands)

(Unaudited)

	Parent Guarantor CPI			Issuer CP Int’l			Other Guarantors			Non- Guarantor China			Eliminations			Consolidated
Cash flows from operating activities:
Net loss	$	(21,872	)	$	(305	)	$	(20,057	)	$	(809	)	$	21,171		$	(21,872	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization		1,170			120			31,827			9,830			—			42,947
Amortization of debt issuance cost		140			1,692			—			—			—			1,832
Foreign currency (gains) loss		—			—			815			45			—			860
Loss from early debt extinguishment		—			3,005			—			—			—			3,005
(Gain) loss on sale of equipment		—			—			(78	)		13			—			(65	)
Equity income from investment in subsidiaries		20,362			—			809			—			(21,171	)		—
Changes in assets and liabilities:
Intercompany accounts receivable		(144,546	)		13,682			(1,422	)		(7,671	)		139,957			—
Accounts receivable		13			9			(5,838	)		(33	)		—			(5,849	)
Inventories		—			—			(2,604	)		(948	)		—			(3,552	)
Prepaid expenses and other current assets		(535	)		(38	)		(435	)		(579	)		—			(1,587	)
Other assets		367			(65	)		(4,573	)		(586	)		—			(4,857	)
Intercompany accounts payable		510			110,072			26,975			2,400			(139,957	)		—
Accounts payable		(109	)		(691	)		3,041			1,780			—			4,021
Accrued expenses and other current liabilities		3,203			(7,351	)		2,873			1,248			—			(27	)
Other long-term liabilities		—			—			4,796			—			—			4,796
Net cash provided by (used in) operating activities		(141,297	)		120,130			36,129			4,690			—			19,652
Cash flows from investing activities:
Acquisition of property, plant and equipment		(66	)		(3,837	)		(41,920	)		(12,176	)		—			(57,999	)
Acquisition of intangible assets		(462	)		—			(2,015	)		(67	)		—			(2,544	)
Proceeds from sale of equipment		—			—			86			—			—			86
Malaysian acquisition, net of cash and cash equivalents acquired		—			—			(5,873	)		—			—			(5,873	)
Investment in subsidiaries		—			—			(7,507	)		—			7,507			—
Net cash used in investing activities		(528	)		(3,837	)		(57,229	)		(12,243	)		7,507			(66,330	)
Cash flows from financing activities:
Proceeds from revolving loan and other lines of credit		—			100,000			5,596			—			—			105,596
Repayment of revolving loan		—			(100,000	)		(5,596	)		—			—			(105,596	)
Increase in debt issuance costs		—			(703	)		—			—			—			(703	)
Net proceeds from long-term debt		—			(82,440	)		16,700			—			—			(65,740	)
Repayment of notes from stockholders		505			—			—			—			—			505
Intercompany loan payments		—			—			—			7,507			(7,507	)		—
Proceeds from common stock issuance		167,105			—			—			—			—			167,105
Repurchase of common stock		(24	)		—			—			—			—			(24	)
Net cash provided by (used in) financing activities		167,586			(83,143	)		16,700			7,507			(7,507	)		101,143
Net increase (decrease) in cash		25,761			33,150			(4,400	)		(46	)		—			54,465
Cash and cash equivalents at beginning of period		1,842			17,093			20,939			1,998			—			41,872
Cash and cash equivalents at end of period	$	27,603		$	50,243		$	16,539		$	1,952		$	—		$	96,337

18

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

All references are to ChipPAC’s fiscal quarters ended September 30, 2003 and September 30, 2002, unless otherwise indicated. This quarterly report on Form 10-Q contains forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “target,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and speak only as of their dates. These forward-looking statements are based on our current expectations and are subject to a number of risks and uncertainties, including those identified under Exhibit 99.1 filed with our annual report on Form 10-K for the year ended December 31, 2002 and other risks and uncertainties indicated from time to time in our filings with the SEC. Actual results could differ materially from these forward-looking statements. In addition, important factors to consider in evaluating these forward-looking statements include changes in external market factors, changes in our business or growth strategy or an inability to execute our strategy due to changes in our industry or the economy generally, the emergence of new or growing competitors and various other competitive factors. Also, terrorist acts, war, political unrest or disease epidemics in the regions where we have operations could materially affect our financial condition and our results of operation. In light of these risks and uncertainties, there can be no assurance that the matters referred to in the forward-looking statements contained in this quarterly report will in fact occur.

Results of Operations

Three and nine month periods ended September 30, 2003 compared to three and nine month periods ended September 30, 2002

Revenue.    Revenue was $105.4 million and $300.8 million for the three and nine month periods ended September 30, 2003, respectively, an increase of 11.4% and 11.0% compared to revenue of $94.7 million and $271.0 million for the same periods in 2002, respectively. New customers were added in the latter half of 2002 and these new customers have been increasing production since the beginning of the year. In addition, we have expanded our products and services to our existing customer base in 2003. These factors contributed to the increase of revenue over the same periods in 2002. We expect that demand and revenue will continue to improve. Assembly unit volumes for the three and nine month periods ended September 30, 2003, increased 12.2% and 9.6%, respectively, over the same periods in 2002. Average selling prices per pin for the three and nine month periods ended September 30, 2003, decreased 10.4% and 5.4%, respectively, compared to the same periods in 2002.

Gross Profit.    Gross profit during the three and nine month periods ended September 30, 2003 was $13.0 million and $39.7 million, a decrease of 18.8% and 8.4% compared to gross profit of $16.0 million and $43.3 million for the same periods in 2002, respectively. Gross margin as a percent of revenue was 12.4% and 13.2% for the three and nine month periods ended September 30, 2003, as compared to 16.9% and 16.0% in the same period in 2002, respectively. For the three and nine month periods ended September 30, 2003 compared to the same period in 2002, gross profit percentage declined due to substrate pricing increases, lower margin products making up a larger weighted factor in our overall product mix, rising costs of materials in reaction to macroeconomic issues including South Korean exchange rate valuations and increased gold market prices and non-recurring expenses of $0.6 million related to inventory write downs and facility moving expenses. Overall equipment utilization was approximately 60.2 % for the three month period ended September 30, 2003 as compared to 63.0 % in the same period in 2002. We expect gross profit to improve as a result of our restructuring.

Selling, General, and Administrative.    Selling, general and administrative expenses were $10.3 million and $28.2 million for the three and nine month periods ended September 30, 2003 as compared to $9.4 million and $29.0 million for the same periods in 2002. Selling, general and administrative expenses increased 10.2% for the three month period ended September 30, 2003 as compared to the same period in 2002. For the nine month period ended September 30, 2003, selling, general and administrative expenses decreased 2.5% compared to the same period in 2002. As a percentage of revenue, selling, general and administrative expenses were 9.8% and 9.4% for the three and nine month periods ended September 30, 2003, respectively, compared to 9.9% and 10.7% for the same periods in 2002, respectively. During the three month period ended September 30, 2003, expenses increased primarily from activities related to selling expenses. The decrease in expenses as a percentage of revenue for the nine month period for September 30, 2003 expenses compared to the 2002 periods was due to cost and hiring controls keeping spending under the percentage increase in revenue.

Research and Development.    Research and development expenses for the three and nine month periods ended September 30, 2003 were $2.7 million and $8.7 million, respectively, versus $2.6 million and $7.3 million for the same periods in 2002, an increase of 7.0% and 19.7% from the three and nine month periods ended September 30, 2002, respectively. Throughout 2003, we have continued to increase our research and development staffing and projects at all three of our plants. The increased staffing and increased number of projects in 2003 drove the additional spending compared to the same periods in 2002.

19

Restructuring Charge and Write Down of Impaired Assets.    During the three month period ended September 30, 2003, restructuring plans were executed to realign our organization and reduce operating costs to better align our expenses with revenues. As of September 30, 2003, we had a total reduction of 252 personnel related to the restructuring. Restructuring and related charges of $1.9 million were expensed during the three month period ended September 30, 2003.

In addition, during the three month period ended September 30, 2003, we wrote down impaired assets by $11.7 million. We determined that the expected cash flows related to certain manufacturing equipment was not sufficient to recover the carrying value of the equipment. As the result of this, the carrying values of these assets were written down to the estimated fair market value and will continue to be depreciated over the remaining useful lives. There were no equivalent write-offs in the same period during 2002.

Interest Expense.    Total outstanding interest-bearing debt was $365.0 million at September 30, 2003 versus $317.9 million at September 30, 2002. The increase in debt outstanding of $47.1 million from September 30, 2002 to September 30, 2003, is attributable to the issuance of $150.0 million convertible debt in May 2003 offset by the pay down of $102.9 million of term loans and other lines of credits and revolver loans. Related interest expense was $7.9 million and $22.8 million for the three and nine month periods ended September 30, 2003, an increase of 2.9% as compared to $7.7 million for the three month period and a decrease of 6.8% as compared to $24.5 million for the nine month period ended September 30, 2002. Despite the increase in total outstanding debt at September 30, 2003 as compared to September 30, 2002, interest expense decreased primarily as the result of lower interest rates on the new convertible debt that replaced debt with significantly higher rates. Total interest expenses paid in cash for the nine months ended September 30, 2003 were $24.8 million.

Foreign Currency Losses.    Net foreign currency losses were $0.3 million and $0.5 million for the three and nine month periods ended September 30, 2003, respectively, as compared to a net foreign currency gain of $0.5 million for the same three month period in 2002 and a net foreign currency loss of $0.9 million for the same nine month period in 2002. These non-cash losses were primarily due to the fluctuations between the exchange rate of the United States Dollar and the South Korean Won related to long-term severance benefits payable to our South Korean employees in Korean Won.

Loss From Early Extinguishment of Debt.    In May and June 2003, we issued $150.0 million of 2.5% convertible subordinated notes in a private placement and used a portion of the proceeds to payoff term loans and foreign debt. As a result of the early extinguishment of these loans and debt, associated capitalized debt issuance cost of $1.2 million In May 2002, we used proceeds from our secondary public offering to pay off term loans. As the result of this early extinguishment of debt, associated capitalized debt issuance cost of $3.0 million were written-off. There were no additional related expenses in the three month period ended September 30, 2003.

Income Taxes.    Consolidated income tax provisions were $0.5 million and $1.5 million for both of the three and nine month periods ended September 30, 2003 and 2002, respectively. We have a mix of tax rates across the various jurisdictions in which we do business, and our current estimated provision for 2003 is $2.0 million with $0.5 million recognized in the three month period ended September 30, 2003. This estimate does not take into account any future benefit from loss carryforwards, which we may realize once we again achieve profitability and begin generating taxable income.

Critical Accounting Policies

For critical accounting policies affecting us, see Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2002. Critical accounting policies affecting us have not changed materially since December 31, 2002.

Liquidity and Capital Resources

Our ongoing primary cash needs are for operations and equipment purchases. We spent $30.9 million and $75.7 million on capital expenditures during the three and nine month periods ended September 30, 2003, respectively, as compared to $18.1 million and $58.0 million in capital expenditures during the same periods in 2002, respectively. In addition, $3.5 million was invested for the Cirrus Logic’s back-end wafer probe and test assets.

As of September 30, 2003, our total debt consisted of $365.0 million of borrowings, which was comprised of $165.0 million of 12.75% senior subordinated notes, $50.0 million of 8.0% convertible subordinated notes and $150.0 million of 2.5% convertible subordinated notes.

20

Our senior credit facilities, as amended, contain covenants restricting our operations and requiring that we meet specified financial tests. The financial covenants consist solely of a minimum interest coverage ratio and a maximum senior leverage ratio based on a rolling 12-months calculation. There were no violations of the covenants under the senior credit facilities, as amended, through September 30, 2003.

Other than the covenants on the debt as discussed above and the tax guarantee to the Korean Tax Authorities and discussed below, we have no performance guarantees. We also have no investment in any unconsolidated entities. Our off-balance sheet commitments are limited to equipment operating leases, royalty/license agreements, and leases on office and manufacturing space. Our total off-balance sheet obligations are approximately $56.2 million as of September 30, 2003.

Our total commitments on our loans, operating leases, and other agreements as of September 30, 2003, were as follows (in thousands):

	Total		Within 1 Year		2–3 Years		4–5 Years		After 5 Years
On balance sheet commitments:
Senior subordinated notes	$	165,000	$	—	$	—	$	—	$	165,000
Convertible subordinated notes		200,000		—		—		150,000		50,000
Total on balance sheet commitments		365,000		—		—		150,000		215,000
Off balance sheet commitments:
Operating leases		55,009		2,361		12,757		10,782		29,109
Royalty/licensing agreements		1,148		66		802		280		—
Total off balance sheet commitments		56,157		2,427		13,559		11,062		29,109
Total commitments	$	421,157	$	2,427	$	13,559	$	161,062	$	244,109

During the quarter ended June 30, 2002, an assessment of approximately 16.0 billion Korean Won (approximately $13.9 million U.S. Dollars at September 30, 2003), was made by the Korean National Tax Administration, or NTA, relating to withholding tax not collected on the loan between our subsidiaries in Korea and Hungary. The prevailing tax treaty does not require withholding on the transactions in question. There were no further assessments made during the quarter ended September 30, 2003. We have appealed the assessment through the NTA’s Mutual Agreement Procedure and believe that the assessment will be overturned. As of September 30, 2003, no accrual has been made. On July 18, 2002, the Icheon tax office of the NTA approved a tax suspension of the proposed assessment until resolution of the disputed assessment. The NTA required a corporate guarantee of 120% of the assessment in exchange for the suspension. We complied with the guarantee request on August 1, 2002. No further assessments have been made.

For the nine month periods ended September 30, 2003 and 2002, cash provided by operations was $17.8 million and $19.7 million, respectively. Cash provided by operations is calculated by adjusting our net loss by non-cash related items such as depreciation and amortization, debt issuance cost amortization, write down of impaired assets, gains from sale of assets, loss from early extinguishment of debt and foreign currency loss and by changes in assets and liabilities. During the nine month period ended September 30, 2003, non-cash related items included $50.9 million related to depreciation and amortization, $1.6 million from debt issuance costs, $11.7 million from write down of impaired assets, $4.3 million from gain on sale of assets, $1.2 million loss from early extinguishment of debt and $0.5 million from foreign currency loss. Working capital uses of cash included increases in accounts receivable, inventories, prepaid assets, and a decrease in accrued liabilities, primarily due to interest payments made. Working capital sources of cash primarily was due to an increase in accounts payable.

For the nine month period ended September 30, 2003, cash used in investing activities was $112.1 million versus $66.3 million for the same period in 2002. During the nine month period ended September 30, 2003, $75.7 million was used for capital expenditures and $3.5 million was invested in Cirrus Logic’s back-end wafer probe and test assets. In addition, the final $3.5 million was invested in the purchase of the Malaysian business, including purchased intellectual property. Proceeds from sale of assets were $5.9 million, which includes $5.5 million related to the sale of our building in Malaysia.

For the nine month period ended September 30, 2003, cash provided by financing activities was $98.2 million as compared to $101.1 million for the same period in 2002. In May and June 2003, $144.9 million, after deducting transaction costs, was provided by the issuance of subordinated convertible notes in a private placement. As of September 30, 2003, there were no outstanding borrowing on the revolving loan and the line of credit facilities. During the nine month period ended September 30, 2003, $6.1 million was provided by the issuance of new common stock through the employee stock purchase plan and employee stock option plans.

21

The terms of the acquisition of the Malaysian business required contingent incentive payments to Intersil, up to a maximum of $17.9 million through June 30, 2003. There were no additional accruals related to the acquisition in the three month period ended September 30, 2003. Cumulatively we have paid $17.9 million under this arrangement, which completed our required payments.

On January 30, 2002, we sold 10,000,000 shares of Class A common stock in an underwritten public offering for $6.00 per share. On February 14, 2002, we sold an additional 1,425,600 shares of Class A common stock in conjunction with the underwriter’s exercise of their over-allotment option at the public offering price for $6.00 per share. In connection with these sales, we received net proceeds of approximately $63.8 million, after deducting underwriting discounts, commissions and offering expenses. Net proceeds of $62.4 million from this offering were used to pay down term loans and revolving loans. The remaining $1.4 million was used for general corporate purposes.

On May 30, 2002, we sold 12,000,000 shares of Class A common stock in an underwritten public offering for $8.75 per share. In connection with this sale, we received net proceeds of approximately $99.2 million, after deducting underwriting discounts, commissions and offering expenses. Net proceeds of $50.0 million from this offering were used to pay down term loans. The remaining $49.2 million was used for general corporate purposes.

On May 28, 2003, we issued $125.0 million of 2.5% convertible subordinated notes due 2008 in a private placement and on June 5, 2003, the initial purchaser exercised the option to purchase an additional $25.0 million of 2.5% convertible subordinated notes under the same terms. The $150.0 million of 2.5% convertible subordinated notes are convertible into shares of our Class A common stock at a conversion price of $8.062 per share, subject to adjustment at any time prior to June 1, 2008 and bear an interest rate of 2.5% per annum. We used $63.9 million from the proceeds of these notes to pay down $36.2 million of our term loans, $16.7 million of foreign loan of and $11.0 million of revolving loans. The remaining $61.1 million is being used for general corporate purposes.

We believe that our existing cash balances, cash flows from operations and available borrowings under our senior credit facilities of $50.0 million will provide sufficient cash resources to meet our projected operating and other cash requirements for the next twelve months. An event of default under any debt instrument, if not cured or waived, could have a material adverse effect on us. We may require capital sooner than currently expected. We cannot assure you that additional financing will be available when we need it or, if available, that it will be available on satisfactory terms. In addition, the terms of our senior credit facilities and senior subordinated notes significantly reduce our ability to incur additional debt. Failure to obtain any such required additional financing could have a material adverse effect on our company.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

For quantitative and qualitative disclosures about market risks affecting us, see Item 7A “Quantitative Disclosure About Market Risk” of our Annual Report on Form 10-K for the year ended December 31, 2002. Our exposure to market risks has not changed materially since December 31, 2002.

ITEM 4. CONTROLS AND PROCEDURES

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13a-14 of the Securities Exchange Act of 1934 (the “Exchange Act”). Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective, as of September 30, 2003, in timely alerting them to material information relating to our company (including its consolidated subsidiaries) required to be included in our Exchange Act filings.

There have been no changes in our internal controls over financial reporting during the fiscal quarter ended September 30, 2003 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

22

PART II.    OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not involved in any legal proceedings the outcome of which we believe would have a material adverse effect on our business, financial condition or results of operations. From time to time, however, we are involved in claims that arise in the ordinary course of business, and we maintain insurance that we believe to be adequate to cover these claims.

ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS

Not applicable

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None

ITEM 5. OTHER INFORMATION

Not applicable

ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K

2.1	Amended and Restated Agreement and Plan of Merger of ChipPAC, Inc., a California corporation, and ChipPAC, Inc., a Delaware corporation.**
2.2	Agreement and Plan of Recapitalization and Merger, dated as of March 13, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*
2.3	First Amendment to Agreement and Plan of Recapitalization and Merger, dated as of June 16, 1999 by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*
2.4	Second Amendment to Agreement and Plan of Recapitalization and Merger, dated as of August 5, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc. and ChipPAC Merger Corp.*
3.1	Amended and Restated Certificate of Incorporation of ChipPAC, Inc.**
3.2	Amended and Restated By-Laws of ChipPAC, Inc.**
4.1	Specimen certificate for ChipPAC, Inc. Common Stock.**
10.1	Credit Agreement, dated as of August 5, 1999, as amended and restated as of June 30, 2000, by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent, Sole Lead Manager and Collateral Agent.*
10.2	Guaranty, dated as of August 5, 1999, by and among ChipPAC, Inc. and certain subsidiaries of ChipPAC, Inc., in favor of Credit Suisse First Boston (incorporated by reference to Exhibit 4.5 of the Company’s registration statement on Form S-3 (Registration No. 333-69704)).
10.3	Amendment No. 1 to Amended and Restated Credit Agreement, dated as of March 13, 2001, by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent, Sole Lead Manager and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2002 (No. 000-31173)).

23

10.4	Amendment No. 2 to Amended and Restated Credit Agreement, as amended, dated as of December 31, 2001 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001 (No. 000-31173)).
10.5	Amendment No. 3 to Amended and Restated Credit Agreement, as amended, dated as of December 31, 2001 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K (No. 000-31173)).
10.6	Amendment No. 4 to Amended and Restated Credit Agreement, as amended, dated as of May 17, 2002 by and among ChipPAC International Company Limited, ChipPAC, Inc, the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended September 30, 2002).
10.7	Subsidiary Guaranty Agreement, dated as of August 5, 1999, by and among ChipPAC Korea Company Ltd., ChipPAC Limited, ChipPAC (Barbados) Ltd., ChipPAC Luxembourg S.a.R.L., ChipPAC Liquidity Management Hungary Limited Liability Company and ChipPAC International Company Limited, in favor of Firstar Bank of Minnesota, N.A.*
10.7.1	Subsidiary Guaranty Agreement, dated as of October 12, 2001, by ChipPAC Malaysia Sdn. Bhd, in favor of U.S. Bank, N.A.(incorporated by reference to Exhibit 4.7 of the Company’s registration statement on Form S-3 (Registration No. 333-69704)).
10.8	Amended and Restated Registration Agreement, dated as of August 5, 1999, by and among ChipPAC, Inc. the Hyundai Group (as defined therein), the Bain Group (as defined therein), the SXI Group (as defined therein), Intel Corporation, ChipPAC Equity Investors LLC, and Sankaty High Yield Asset Partners, L.P.*
10.8.1	Amendment No. 1 to Amended and Restated Registration Agreement, dated as of June 30, 2000, by and among ChipPAC, Inc., Sapphire Worldwide Investments, Inc., the Bain Stockholders (as defined therein) and SXI Group LLC.**
10.8.2	Form of Amendment No. 2 to Amended and Restated Registration Agreement, dated as of July 13, 2000, by and among ChipPAC, Inc., Qualcomm Incorporated, SXI Group LLC and the Bain Shareholders (as defined therein).**
10.8.3	Form of Amendment No. 3 to Amended and Restated Registration Agreement, dated as of August 2, 2000, by and among ChipPAC, Inc., Bain Capital, Inc., SXI Group LLC and the Bain Shareholders (as defined therein).**
10.9	Transition Services Agreement, dated as of August 5, 1999, by and among Hyundai Electronics Industries Co., Ltd., Hyundai Electronics America, ChipPAC, Inc., ChipPAC Korea Company Ltd., Hyundai Electronics Company (Shanghai) Ltd., ChipPAC Assembly and Test (Shanghai) Company Ltd., ChipPAC Barbados Limited and ChipPAC Limited.*
10.10	Lease Agreement, dated as of June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.10.1	Amendment Agreement, dated September 30, 1998, to Lease Agreement, dated June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.10.2	Amendment Agreement 2, dated September 30, 1999, to Lease Agreement, dated June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.11	Agreement Concerning Supply of Utilities, Use of Welfare Facilities and Management Services for Real Estate, dated as of June 30, 1998, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Korea Ltd.*
10.12	Service Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries Co., Ltd. and ChipPAC Limited.+*
10.13	Sublease Agreement, dated as of May 1, 1998, by and between Hyundai Electronics America and ChipPAC, Inc.*
10.14	Employment letter agreement, dated as of January 10, 2003 between ChipPAC, Inc. and Robert Krakauer. (Incorporated by Reference to the Company’s Annual Report on Form 10-K for the period December 31, 2002)

24

10.15	Employment letter agreement, dated as of January 13, 2003 between ChipPAC, Inc. and Patricia McCall. (Incorporated by Reference to the Company’s Annual Report on Form 10-K for the period December 31, 2002)
10.16	Employment Agreement, dated as of October 1, 1999, between ChipPAC, Inc. and Dennis McKenna.*
10.17	ChipPAC, Inc. 1999 Stock Purchase and Option Plan.*
10.18	ChipPAC, Inc. 2000 Equity Incentive Plan.**
10.19	ChipPAC, Inc. 2000 Employee Stock Purchase Plan.**
10.20	Form of Key Employee Purchased Stock Agreement.*
10.20.1	Form of Key Employee Purchased Stock Agreement (with Loan).*
10.21	Form of Employee Restricted Stock Agreement.*
10.22	Form of Directors Tranche I Stock Option Agreement.*
10.23	Form of Employees Tranche I Stock Option Agreement.*
10.24	Form of Tranche II Stock Option Agreement.*
10.25	Indenture, dated as of July 29, 1999, by and among ChipPAC International Limited, ChipPAC Merger Corp. and Firstar Bank of Minnesota, N.A., as trustee.*
10.26	First Supplemental Indenture, dated as of August 5, 1999, by and among ChipPAC International Company Limited, ChipPAC, Inc. and Firstar Bank of Minnesota, N.A., as trustee.*
10.27	12.75% Senior Subordinated Notes Due 2009.*
10.28	Form of Series B 12.75% Senior Subordinated Notes Due 2009.*
10.29	Intellectual Property Rights Agreement, entered into as of June 30, 2000, by and between Intersil Corporation and ChipPAC Limited.**
10.30	Supply Agreement, entered into as of June 30, 2000, by and between Intersil Corporation and ChipPAC Limited.**
10.31	Employment letter agreement, dated as of November 15, 1999 between ChipPAC, Inc. and Robert Krakauer (incorporated by reference to the Company’s annual report on Form 10-K for the period December 31, 2000).
10.32	Employment letter agreement, dated as of October 4, 2000 between ChipPAC, Inc. and Richard Freeman (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
10.33	Employment letter agreement, dated as of October 9, 2000 between ChipPAC, Inc. and Patricia McCall (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001).
10.34	Indenture, dated as of June 15, 2001, by and between ChipPAC, Inc. and Firstar Bank, N.A. as trustee (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
10.35	Registration Rights Agreement, dated June 22, 2001, by and between ChipPAC International Company Limited and Citicorp Capital Investors Limited (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).
10.36	Registration Rights Agreement, dated June 22, 2001, by and between ChipPAC, Inc. and Citicorp Mezzanine III, L.P. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2001).

25

10.37	Patent and Technology License Agreement, dated as of August 5, 1999, by and between Hyundai Electronics Industries, Co., Ltd. and ChipPAC Limited (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2001). +
10.38	Amendment No. 5 to Amended and Restated Credit Agreement, as amended, dated as of May 19,2003 by and among ChipPAC International Company Limited, ChipPAC, Inc., the Lenders listed therein and Credit Suisse First Boston, as Administrative Agent and Collateral Agent (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2003).
10.39	Registration Rights Agreement, dated March 28, 2003, by and between ChipPAC Inc. and Lehman Brothers Inc. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2003).
10.40	Indenture, dated as of May 28, 2003, by and between ChipPAC, Inc. and U.S. Bank National Association, as trustee. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended June 30, 2003).
10.41	Settlement Agreement and General Release, dated as of September 26, 2003, between Richard Freeman and ChipPAC, Inc.
21.1	Subsidiaries of ChipPAC, Inc., ChipPAC International Company Limited, ChipPAC (Barbados) Ltd., ChipPAC Limited, ChipPAC Liquidity Management Limited Liability Company, ChipPAC Luxembourg S.a.R.L. and ChipPAC Korea Company Ltd. (incorporated by reference to the Company’s quarterly report on Form 10-Q for the period ended on June 30, 2002).
31.1	Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1	Risk Factors (incorporated by reference to the Company’s annual report on Form 10-K for the year ended December 31, 2002).

* Incorporated by reference to the Company’s Form S-4 (No. 333-91641).

** Incorporated by reference to the Company’s Form S-1 (No. 333-39428).

+ Confidential treatment has been granted as to certain portions of these exhibits, which are incorporated by reference.

(b) Reports on Form 8-K.

On July 31, 2003, we furnished a Current Report on Form 8-K to the SEC, reporting our earnings and including the Company’s press release announcing financial results for the three and six month periods ended June 30, 2003.

26

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, as of November 12, 2003.

CHIPPAC, INC.

(Registrant)

/s/    ROBERT KRAKAUER

ROBERT KRAKAUER

Senior Vice President and Chief Financial Officer

/s/    MICHAEL G. POTTER

MICHAEL G. POTTER

Vice President, Controller and Chief Accounting Officer

27

EX-10.41

Exhibit 10.41

SETTLEMENT AGREEMENT AND GENERAL RELEASE

This Settlement Agreement and General Release (hereinafter “Agreement”) is entered into as of this 26th day of September, 2003 (“Effective Date”), by and between Richard Freeman (hereinafter “Employee”) and ChipPAC, Inc. (hereinafter the “Company”).

WHEREAS, Employee and Company have agreed that Employee’s active duties at the Company will be discontinued no later than November 30, 2003; and

WHEREAS, Employee and Company have agreed that Employee’s employment with the Company will terminate on November 30, 2003; and

WHEREAS, Company desires to provide certain benefits to Employee in connection with the termination of Employee’s employment on the terms specified in the Employment Agreement entered into between Employee and the Company on October 4, 2000 and detailed herein; and

WHEREAS, Company and Employee acknowledge that the benefits specified herein are greater than Employee would otherwise be entitled to upon termination of his employment; and

WHEREAS, Company and Employee desire to settle fully and finally all differences between them and to mutually release each other;

NOW, THEREFORE, in consideration of the mutual covenants and promises set forth herein, Employee and Company agree as follows:

1.    Employee’s last day of employment with Company will be November 30, 2003. From September 26, 2003 through a date to be determined by the CEO (“the Transition Date”), but no later than November 30, 2003, Employee will assist with the transition of his duties to others. From the Transition Date through November 30, 2003, Employee will be relieved of his regular duties at the Company, but will be available to provide support to the Company as needed upon reasonable notice at the direction of the CEO. Employee shall resign his title of Senior Vice President and Chief Operating Officer at the Transition Date. The Company’s internal records shall reflect that Employee’s employment terminated as a result of voluntary resignation on November 30, 2003 (the “Termination Date”).

2.    From and after the Transition Date, as consideration for this Agreement, and in lieu of any other severance or other payment, ChipPAC will continue to pay Employee’s base salary (at current levels and less any withholdings required by

law) for an additional period of eight months. If during this eight month period, Employee accepts other employment, Employee shall immediately so notify the Company’s Vice President, Human Resources, and any further payments to be made under this paragraph shall be reduced by the amount of any compensation so received by Employee during this eight month period. Employee agrees that during this eight month period, Employee will not engage in employment with, or provide consulting services for, any competitor of the Company, and will not hire or solicit any Company employee; if Employee breaches this provision, any remaining salary payments will immediately cease and Company may seek damages and an injunction against Employee.

3.    Employee will be eligible to receive a STI bonus payment for 2003 prorated for the days of the performance period for which Employee would have otherwise been eligible, up to the Transition Date, and provided the company has achieved its targets such that a bonus is paid out to other eligible participants for that performance period, but will not be eligible for bonus payments thereafter. Any payment will be subject to the terms of the plan and goals achieved, as measured by the CEO and approved by the Board of Directors. Any award will be paid at the same time other employees receive their payments.

4.    Employee’s existing stock options will continue to vest through the Termination Date, in accordance with the terms of the relevant stock option agreements and plan provisions. Employee shall have the right to exercise vested stock options in accordance with the relevant stock option agreements and plan provisions. The exercise period specified in the stock option agreements upon termination of employment will run from the Termination Date, excluding any trading blackout periods. Employee agrees that he is subject to the Company’s trading blackout periods because of the position he has held as an Executive Officer of the Company, as defined under Section 16 of the Securities Exchange Act of 1934. Employee agrees that pursuant to the Company’s trading blackout policy, unless with permission from the General Counsel in an open window period, he will not sell the Company’s stock, or exercise and sell stock options of the Company, earlier than two business days following the Company’s Q4 2003 earnings release. Employee acknowledges that the Company may set the trading blackout period within its sole discretion. The Company agrees to notify Employee in writing of any alteration to this trading blackout period or any other trading blackout period or open window period potentially affecting the exercise period of Employee’s stock options. The Company agrees to provide such notification prior to the effective start date of the trading blackout period. Employee agrees to notify the Company’s General Counsel within twenty-four (24) hours of any trade made within six (6) months of his resignation from the position of Senior Vice President and Chief Operating Officer by, or on behalf of, Employee, his immediate family or anyone under his control, in order to allow the Company to fulfill the relevant reporting requirements on Employee’s behalf.

5.    Employee’s vacation accrual shall cease on the Transition Date and any vacation accrued as of this date but remaining unused or unpaid will be paid to Employee by this date. Employee’s medical and dental coverage shall terminate on November 30, 2003. Thereafter, Employee is responsible for maintaining medical and

dental coverage under COBRA or otherwise. Life insurance, accidental death, disability and dependent life insurance coverages shall end on the Transition Date. Employee may convert the life insurance coverage to single policy coverage within thirty (30) days thereafter. Any other benefits due Employee upon termination of employment under any other plan, program or arrangement that Company makes generally available to its employees shall be determined by the terms of such plan or program.

6.    Employee, on behalf of himself, his representatives, heirs, successors, and assigns does hereby completely release and forever discharge Company and all other affiliated or related companies or divisions, its and their present and former officers, directors, shareholders, agents, employees, attorneys, successors, and assigns (hereinafter collectively “Company”) from all claims, rights, demands, actions, obligations, liabilities and causes of action of any kind or nature whatsoever, known or unknown, which Employee may now have or has ever had against Company, based upon any act or omission by Company prior to the date of execution of this Agreement by Employee, including, but not limited to: (1) any and all claims for damages, declaratory or injunctive relief or attorneys’ fees, arising from or in any way related to his employment at Company, or the termination thereof, including all claims for compensation, bonus (including any ChipPAC incentive bonus or stock program), benefits or severance; (2) any charges or claims arising under any federal, state or local law, statute or regulation, including without limitation rights or claims of age or other discrimination Employee may have under Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act, the California Fair Employment and Housing Act, the California Labor Code, or Claims for disability, including claims under the Americans with Disabilities Act, or retaliation in violation of any applicable law, rule, regulation or order; (3) any claims of breach of contract (express or implied, in fact or in law), breach of the covenant of good faith and fair dealing, estoppel, breach of duty, fraud, deceit, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, violation of public policy, defamation, intentional or negligent infliction of emotional distress or other tortious conduct of any kind; (4) all claims filed or caused to be filed in any court of law or before any state or federal administrative agency before execution of this Agreement; and (5) all claims to attorneys’ fees, however incurred, including, without limitation, fees incurred in connection with any released claims and review of this Agreement; provided, however, that this paragraph does not waive (a) any indemnification rights Employee may have whether as an employee or an officer, pursuant to Labor Code Section 2802, Company Certificate of Incorporation or By-Laws, Indemnification Agreement or Company policy; (b) any vested rights or any workers’ compensation claims (the settlement of which would require approval by the California Workers’ Compensation Appeals Board); or (c) any claims arising from acts or omissions occurring after the date of execution of this Agreement.

7.    Employee acknowledges that by entering into this Agreement he is specifically releasing any claims for age discrimination.

8.    It is understood and agreed that the preceding Paragraph is a full and

final Release covering all known as well as all unknown or unanticipated injuries, debts, claims or damages including, without limitation, those arising from or in any way related to Employee’s employment by Company or the termination thereof. Therefore, Employee waives any and all rights or benefits which he may now have, or in the future may have, under the terms of Section 1542 of the California Civil Code which provides as follows:

A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.

9.    Employee hereby agrees and promises that he will not initiate or cause to be initiated against Company any claim, charge, complaint, demand, suit, action, cause of action, investigation, audit, compliance review or proceeding of any kind, or participate in same, individually or as a representative or member of a class, under any contract (express or implied), law, statute or regulation, federal, state or local, pertaining in any manner whatsoever to the claims, rights, demands, actions, obligations, liabilities, and causes of action herein released, including, without limitation, those relating to his employment by Company or the termination thereof.

10.    Employee acknowledges that he has complied with and will continue to comply with his obligations to Company under applicable laws and contract provisions. Employee agrees that he will hold in strictest confidence, and not use or disclose to any person, firm or corporation without prior express written authorization of the President and CEO of Company, any information, matter or thing of a proprietary or confidential nature, whether or not it is in written, permanent or intangible form (collectively, the Proprietary Information) pertaining to any business of Company. Employee specifically agrees that he will not utilize any information developed during or in connection with his employment at Company in the filing or prosecution of any patent application or patent in the name of any person or entity other than Company. Such Proprietary Information includes, but is not limited to, trade secrets, confidential knowledge, data or other proprietary information relating to Company’s products, processes, know-how, designs, formulas, development or experimental work, computer programs, databases, other original works or authorship, financial or other business information, customer lists, other customer information, or employee information. These obligations with respect to Proprietary Information extend to such information belonging to third parties who may have disclosed such information to Employee as a result of his status as an employee of Company. Employee agrees that he will continue to comply with the Employee Confidential Information and Inventions Agreement or the Proprietary Information and Inventions Agreement signed by him. Employee agrees to return to Company by the Termination Date all Company property, credit cards, documents or other materials or equipment that have been furnished to him by Company, including any and all records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches or other documents or property, or reproductions of any aforementioned items belonging to Company.

11.    Employee agrees not to defame, disparage or criticize Company or its shareholders, directors, officers, employees or business or employment practices at any time, or interfere with the same. In addition, Employee agrees not to engage in any conduct that Employee knows or reasonably should know will damage the reputation of Company or cause third parties to view Company in a less favorable light.

12.    It is understood and agreed that the furnishing of the consideration for this Agreement shall not be deemed or construed as an admission of liability or responsibility by Company for any purpose. Employee and Company agree that this Agreement is being entered into solely for the purpose of avoiding further expense and inconvenience from defending against any claims, rights, demands, actions, obligations, liabilities and causes of action. Company expressly denies liability for any and all claims.

13.    Employee understands and agrees that this Agreement and each and every provision hereof shall be treated by him as confidential and shall not be disclosed directly or indirectly by Employee to any other person, firm, organization or other entity, for any reason, at any time without the prior written consent of Company, unless and until its disclosure is required by law. It shall not constitute a breach of this Agreement for Employee to disclose the terms hereof to his immediate family and to his attorney and his financial advisor and/or accountant; provided, however, that Employee shall be obliged to use his best efforts to assure that such persons do not disclose this Agreement or any provision thereof.

14.    In the event that Employee breaches any term of this Agreement, Company shall have the right to recover consideration paid or provided hereunder.

15.    Should any provision of this Agreement be held invalid or illegal, such illegality shall not invalidate the entire Agreement. Rather, this Agreement shall be construed as if it did not contain the illegal part, and the rights and obligations of the parties shall be construed and enforced accordingly.

16.    No failure to exercise and no delay in exercising any right, remedy or power under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy or power under this Agreement preclude any other or further exercise thereof, or the exercise of any right, remedy or power provided for herein or by law or in equity.

17.    This Agreement shall not be amended or modified in any manner except upon written agreement by the parties.

18.    With respect to any matters under this Agreement that are governed by state law, the parties agree that this Agreement shall be construed and governed

by the laws of the State of California. The language of all parts of this Agreement shall in all cases be construed as a whole, according to its fair meaning, and not strictly for or against any Party.

19.    Any contractual claims that Employee may have against Company, or which Company may have against Employee, in any way related to the subject matter, interpretation, application or alleged breach of this Agreement (“Arbitrable Claims”) shall be resolved by arbitration in Santa Clara County, California. Arbitration shall be final and binding upon the parties and shall be the exclusive remedy for all Arbitrable Claims. Arbitration of Arbitrable Claims shall be in accordance with the national Rules for the Resolution of Employment Disputes of the American Arbitration Association, as amended, and as augmented by this Agreement. Either party shall have the right to demand that the Arbitrator bifurcate the issues of the validity and enforceability of this Agreement for decision prior to consideration of any other issues raised. Either party may bring an action in court to compel arbitration under this Release and to enforce the arbitration award. Notwithstanding the foregoing, Company may enforce in court, without prior resort to arbitration any provision of the Release regarding confidential information, inventions, or covenants not to compete or not to sue. THE PARTIES HEREBY WAIVE ANY RIGHTS THEY MAY HAVE TO TRIAL BY JURY WITH REGARD TO ARBITRABLE CLAIMS.

20.    This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

I HAVE CAREFULLY READ AND UNDERSTAND THIS SETTLEMENT AGREEMENT AND GENERAL RELEASE AND REALIZE THAT IT DEALS WITH MY LEGAL RIGHTS, INCLUDING MY LEGAL RIGHTS TO PURSUE A CLAIM OF AGE DISCRIMINATION. I HAVE HAD AN ADEQUATE OPPORTUNITY TO CONSIDER THIS AGREEMENT. I AM FULLY AWARE OF AND UNDERSTAND ITS CONTENTS AND ITS LEGAL EFFECT, THAT THE PRECEDING PARAGRAPHS RECITE THE SOLE CONSIDERATION FOR THIS AGREEMENT, AND THAT ALL AGREEMENTS AND UNDERSTANDINGS BETWEEN ME AND COMPANY ARE INCLUDED HEREIN.

I HAVE BEEN ENCOURAGED TO CONSULT AN ATTORNEY OF MY OWN CHOICE IN THE NEGOTIATION OF THIS AGREEMENT AND BEFORE EXECUTING THIS AGREEMENT AND HAVE BEEN GIVEN ADEQUATE OPPORTUNITY TO REVIEW IT AND TO CONSULT WITH WHOMEVER I WISH REGARDING ITS PROVISIONS.

I RECEIVED THIS SETTLEMENT AGREEMENT AND GENERAL RELEASE ON SEPTEMBER 26, 2003 AND UNDERSTAND THAT I HAVE BEEN GIVEN UNTIL THE CLOSE OF BUSINESS ON OCTOBER 31, 2003 TO DECIDE WHETHER TO SIGN THIS AGREEMENT. I UNDERSTAND THAT I WILL HAVE AN ADDITIONAL SEVEN DAYS FROM THE DATE OF SIGNING THIS AGREEMENT

DURING WHICH TO REVOKE IT, BY HAND DELIVERING OR FAXING WRITTEN NOTICE OF REVOCATION TO THE COMPANY’S GENERAL COUNSEL. IF I DO NOT REVOKE IT, THE AGREEMENT WILL BECOME FINAL AND BINDING. IF I SIGN THIS AGREEMENT BEFORE OCTOBER 31, 2003, I SHALL WAIVE THE RIGHT TO THE REVIEW PERIOD BUT WILL STILL HAVE THE SEVEN DAYS REVOCATION PERIOD. IF I REVOKE THIS AGREEMENT, IT WILL BE VOID, I WILL NOT BE ENTITLED TO RECEIVE ANY BENEFITS HEREUNDER, AND I WILL HAVE TO RETURN TO THE COMPANY ANY BENEFITS ALREADY PAID HEREUNDER.

I UNDERSTAND THAT THE TERMS OF THIS AGREEMENT WILL NOT BECOME ENFORCEABLE UNTIL THIS REVOCATION PERIOD HAS EXPIRED, AND I WILL NOT RECEIVE THE BENEFITS SET FORTH ABOVE UNTIL AT LEAST EIGHT DAYS FOLLOWING THE DATE OF EXECUTION OF THE AGREEMENT AND RELEASE. BENEFITS MAY BE MAILED TO ME.

I AGREE THAT THE PAYMENTS AND BENEFITS DESCRIBED IN THIS DOCUMENT ARE GREATER THAN THOSE I WOULD RECEIVE ON THE TERMINATION OF MY EMPLOYMENT BUT FOR THE TERMS OF THIS SETTLEMENT AGREEMENT AND GENERAL RELEASE.

I HAVE EXECUTED THIS AGREEMENT AND RELEASE VOLUNTARILY AND OF MY OWN FREE WILL, WITHOUT COERCION AND WITH FULL KNOWLEDGE OF WHAT IT MEANS TO DO SO, AND BASED ON MY OWN JUDGMENT AND NOT IN RELIANCE UPON ANY ORAL OR WRITTEN REPRESENTATIONS OR PROMISES MADE BY COMPANY, OTHER THAN THOSE CONTAINED OR REFERENCED HEREIN.

Dated: October 31, 2003	Employee
	/s/    RICHARD FREEMAN
	Richard Freeman
Dated: September 26, 2003	ChipPAC, Inc.
	By:	/s/    CONNIE FREDERICKSON-BRAY
	Print Name: Connie Frederickson-Bray
	Title: Vice President Human Resources

EX-31.1

Exhibit 31.1

CHIPPAC, INC.

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Dennis P. McKenna, the Chief Executive Officer of ChipPAC, Inc. (the “registrant”), certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2003 of ChipPAC, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. Robert Krakauer, the registrant’s other certifying officer, and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. Robert Krakauer, the registrant’s other certifying officer, and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 12, 2003

/s/    DENNIS P. MCKENNA        

Dennis P. McKenna

Chief Executive Officer

EX-31.2

Exhibit 31.2

CHIPPAC, INC.

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002

I, Robert Krakauer, the Chief Financial Officer of ChipPAC, Inc. (the “registrant”), certify that:

1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2003 of ChipPAC, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4. Dennis McKenna, the registrant’s other certifying officer, and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. Dennis Mckenna, the registrant’s other certifying officer, and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 12, 2003

/s/    ROBERT KRAKAUER        

Robert Krakauer

Chief Financial Officer

EX-32.1

Exhibit 32.1

CHIPPAC, INC.

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Dennis P. McKenna, in my capacity as Chief Executive Officer of ChipPAC, Inc., a Delaware corporation (“ChipPAC”), and in connection with the Quarterly Report on Form 10-Q filed by ChipPAC with the Securities and Exchange Commission on November 12, 2003 (the “Report”), hereby certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of ChipPAC.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ChipPAC and will be retained by ChipPAC and furnished to the Securities and Exchange Commission or its staff upon request.

IN WITNESS WHEREOF, the undersigned has executed this CEO Certification as of the 12th day of November, 2003.

/s/    DENNIS P. MCKENNA
Name:	Dennis P. McKenna
Title:	Chief Executive Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by ChipPAC as part of the report or as a separate disclosure document for purposes of Section 18 or any other provision of the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CHIPPAC, INC.

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Robert Krakauer, in my capacity as Chief Financial Officer of ChipPAC, Inc., a Delaware corporation (“ChipPAC”), and in connection with the Quarterly Report on Form 10-Q filed by ChipPAC with the Securities and Exchange Commission on November 12, 2003 (the “Report”), hereby certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1.    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934.

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of ChipPAC.

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to ChipPAC and will be retained by ChipPAC and furnished to the Securities and Exchange Commission or its staff upon request.

IN WITNESS WHEREOF, the undersigned has executed this CFO Certification as of the 12th day of November, 2003.

/s/    ROBERT KRAKAUER
Name:	Robert Krakauer
Title:	Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by ChipPAC as part of the report or as a separate disclosure document for purposes of Section 18 or any other provision of the Securities Exchange Act of 1934, as amended.